Akero Therapeutics Inc

Akero Therapeutics Inc

AKRO

Market Cap$3B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Akero Therapeutics IncAkero Therapeutics Inc-10.5--32%--
$5.06

Current Fair Value

86.9% downside

Overvalued by 86.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.00 Billion
Enterprise Value$2.69 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.75
Beta-0.18
Outstanding Shares70,573,609

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.54
PEG-12.64
Price to Sales-
Price to Book Ratio3.85
Enterprise Value to Revenue9480.01
Enterprise Value to EBIT-10
Enterprise Value to Net Income-12
Total Debt to Enterprise0.01
Debt to Equity0.05

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Akero Therapeutics Inc